Evidence map›Paper›PMID 40503833›Full record

ArticleMicrobiology spectrum2025

A fluorescence-based protocol to monitor bacterial antagonism.

Justin M Luu, Cristian V Crisan, Morgan L Pettis, Anayancy Ramos Facio, Timothy D Read, Joanna B Goldberg

Abstract read
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Justin M LuuMicrobiology and Molecular Genetics Program, Graduate Division of Biological and Biomedical Sciences, Laney Graduate School, Emory University, Atlanta, Georgia, USA.ORCID 0009-0005-3562-7529
Cristian V CrisanDivision of Pulmonary, Asthma, Cystic Fibrosis, and Sleep, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.ORCID 0000-0002-3455-8569
Morgan L PettisDepartment of Biology, Emory University, Atlanta, Georgia, USA.
Anayancy Ramos FacioMicrobiology and Molecular Genetics Program, Graduate Division of Biological and Biomedical Sciences, Laney Graduate School, Emory University, Atlanta, Georgia, USA.ORCID 0000-0003-2275-0956
Timothy D ReadDivision of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.ORCID 0000-0001-8966-9680
Joanna B GoldbergDivision of Pulmonary, Asthma, Cystic Fibrosis, and Sleep, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.ORCID 0000-0002-5285-5188

Funding

Genomics of S. Aureus Colonization after Initial and Recurrent Skin Infections and the Impact of AntibioticsR01AI139188 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI DAVID, MICHAEL ZDENEK · 2018 to 2022
$3.8M
Staphylococcus aureus SPREAD (S. aureus Study of Prevalence Resistance and Environmental Dissemination)R01AI158452 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Michael Zdenek David · 2022 to 2026
$3.5M
CDC HHS CK22-22204 367Cystic Fibrosis Foundation CRISAN22F0Howard Hughes Medical InstituteNIAID NIH HHS R01 AI139188NIAID NIH HHS R01 AI158452NIH HHS AI139188NIH HHS AI15842
6 · The paper itself

Abstract

Bacteria are often found in polymicrobial communities where competition for limited space and resources drives antagonistic interactions. Therefore, bacteria have evolved various antibacterial weapons to outcompete their neighbors. These antagonistic interactions can have profound effects on the structure, dynamics, and composition of bacterial communities. To study interactions between two bacterial species, co-culture assays are often employed. The most common approach utilizes selection plates for each bacterial species to quantify recovery after co-incubation. Although this method is relatively accurate and inexpensive, there are some limitations. These assays can be time-consuming, low-throughput, and may present difficulties if the bacteria of interest show similar resistance patterns to one another or if the tolerance to selective agents is unknown. Here, we have developed and validated a method that uses fluorescence as a proxy to screen antibacterial interactions between two species. We utilized two fluorescently tagged bacteria,

Indexed as

AntibiosisEscherichia coliStaphylococcus aureusAnti-Bacterial AgentsCoculture TechniquesFluorescenceLuminescent ProteinsMicrobial InteractionsPseudomonas aeruginosaRed Fluorescent ProteinStenotrophomonas maltophiliaAnti-Bacterial AgentsLuminescent ProteinsRed Fluorescent Proteinbacterial competitionbacterial killing protocolinterspecies interactions

Identifiers

PMID40503833
PMCPMC12323326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.